Schwerta is the trade name, its generic name is levamlodipine benzenesulfonate; the drug can be used alone or in conjunction with other antihypertensive drugs, there is no such thing as the best match. Levamlodipine Benzenesulfonate is a Western drug, a calcium channel blocker; it is used in the treatment of hypertension and angina pectoris; the adverse effects of this drug include headache, edema, fatigue, insomnia, nausea, abdominal pain, flushing, panic, dizziness, itching, rash, dyspnea, weakness, muscle cramps, and dyspepsia. It is contraindicated in patients who are hypersensitive to this product and other dihydropyridine calcium antagonists. In general, patients can achieve certain therapeutic effects by using the drug alone; when the effect is not too ideal, according to the patient’s specific conditions, under the guidance of the doctor and thiazide diuretics, beta-blockers or angiotensin-converting enzyme inhibitors, and does not need to adjust the dosage; there is no such thing as the best match. Levamlodipine benzenesulfonate should be used under the guidance of a professional doctor, and should not be used blindly on its own to avoid adverse reactions.